GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Ending Cash Position

Ectin Research AB (XSAT:ECTIN B) Ending Cash Position : kr3.92 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Ending Cash Position?

Ectin Research AB's Ending Cash Position for the quarter that ended in Mar. 2024 was kr3.92 Mil.

Ectin Research AB's quarterly Ending Cash Position declined from Sep. 2023 (kr7.88 Mil) to Dec. 2023 (kr5.84 Mil) and declined from Dec. 2023 (kr5.84 Mil) to Mar. 2024 (kr3.92 Mil).

Ectin Research AB's annual Ending Cash Position increased from Aug. 2020 (kr3.44 Mil) to Dec. 2022 (kr13.43 Mil) but then declined from Dec. 2022 (kr13.43 Mil) to Dec. 2023 (kr5.84 Mil).


Ectin Research AB Ending Cash Position Historical Data

The historical data trend for Ectin Research AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Ending Cash Position Chart

Ectin Research AB Annual Data
Trend Aug19 Aug20 Dec22 Dec23
Ending Cash Position
- 3.44 13.43 5.84

Ectin Research AB Quarterly Data
Aug19 Aug20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.75 9.86 7.88 5.84 3.92

Ectin Research AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Ectin Research AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=13.427+-7.591
=5.84

Ectin Research AB's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=5.836+-1.918
=3.92


Ectin Research AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Ectin Research AB (XSAT:ECTIN B) Business Description

Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines